Donate
Search the Community
Showing results for tags 'ofa'.
Found 7 results
-
Click on a link below or scroll down to view each section: HGTD In The News HGTD News From IPFD Initiative Background Key Partners and Leadership Sponsors Executive Summary Timeline HGTD In The News September 14, 2020 IPFD Mentioned in Articles on Australian Labradoodle DNA Study (The Guardian, The Conversation) September 13, 2019: HGTD Interview in Story from ABC 10 (Sacramento, CA) May 16, 2019: HGTD Gets Mention in Story from WGME CBS 13 (Portland, ME) March 8, 2019: USA Today article: DNA testing kits for dogs are super popular. But the testing has some veterinarians pushing standards February 11, 2019: The Associated Press (and various media) article: Dog DNA Testing Takes Off, and Generates Debate November 12, 2018: HGTD featured in The Atlantic: What Vets Think of ‘23andMe for Dogs’ October 3, 2018: IPFD submission responding to “Pet genomics medicine runs wild” published in Nature Visit our IPFD in the Media section for more published articles, commentaries, etc. from outside organizations that reference the HGTD or IPFD. Items in this section related to the HGTD specifically are also presented together in the article In the News: Harmonization of Genetic Testing for Dogs. HGTD News from IPFD December 19, 2018: Update on the Harmonization of Genetic Testing for Dogs (HGTD) Visit our IPFD News section for more news related to the HGTD and other IPFD news. HGTD Initiative Description The IPFD Harmonization of Dogs (HGTD) is a multi-stakeholder, collaborative effort to create an open access, sustainable online resource that: Catalogs information provided voluntarily from genetic test providers (GTPs) including information on their company and services, quality measures and expertise, tests offered and more. We are continually engaging more GTP participants. Has collated and assembled existing and new resources for genetic counselling and education; and provided the foundation for further developments. Will host expert panel reviews of genetic tests and their application. Plans to include a program for standardized proficiency testing and potentially peer review and audit. A related development, the Health Strategy Database for Dogs, will include a comprehensive list of conditions (potentially inherited) by breed, country and organization or group who has developed recommendations (i.e. Health Strategy Providers). This resource will support counseling that considers not only those conditions for which there is a genetic test, but also all those breed disorders/ characteristics that impact health and well-being in breeds. Our Steering Committee includes: Brenda Bonnett, CEO, IPFD; Aimee Llewellyn-Zaidi, HGTD Project Director, IPFD; Diane Brown, AKC Canine Health Foundation; Matthew Breen, North Carolina State University; Cathryn Mellersh, Animal Health Trust; Sofia Malm, Swedish Kennel Club; Wim van Haeringen, VHL Genetics, Netherlands; Sue Pearce-Kelling, Optigen; and Eddie Dzuik; Orthopedic Foundation for Animals (OFA). IPFD, our Partners and other stakeholders in this initiative recognize the input and work of many other experts and organizations in addressing the use of DNA tests in dogs. The Harmonization initiative is working to further engage numerous experts to participate in panels to develop the resource, provide evaluation of tests and work to advance genetic counseling. IPFD actively engaged Leadership Sponsors (see below) to help develop the HGTD Quality Database. These collaborators include international genetic test providers (GTPs), academic institutions, the Hereditary Disease Committee of the World Small Animal Veterinary Association and other important dog health organizations. A prototype was presented at the 3rd International Dog Health Workshop and at the 9th Canine and Feline Genetics and Genomics meeting in Minnesota, May 2017. Beta testing of the Quality Database was completed in early 2018, and it was launched on 7 May 2018. Since the launch, there has been a surge of interest from both the public, and potential new collaborators. The HGTD database was the culmination of months of hard work, building of new collaborations, fundraising, and data management. One of the major IPFD projects, it arose from discussions at the International Dog Health Workshops (IDHWs); the HGTD is a proud achievement, exemplifying the IDHW tagline: Information – Collaboration – Action! We have been pleased to find that people are already using the HGTD Database to help find the right international genetic test provider, and testing information, for their dogs. By publishing details on a test provider’s measure of quality, business and research information, and tests provided – as well as information on hundreds of breed-specific DNA tests – dog owners and health professionals are able to make the most of this project. The growth and development over 2018, and the positive interest from diverse professional and public media - from JAVMA to The Atlantic - has been reassuring that this project is both timely and needed in the world of genetic testing. It has also become apparent that IPFD has an important role to play as an independent voice in discussions on the complex world of genetic testing. See, for example, our response to an article in Nature, where we are able to provide a balanced view of issues. See also, a Improving Canine Genetic Testing, a discussion on standards for GTP labs and broader challenges. This is a field with a diverse array of stakeholders, and encouraging discussions will continue to be part of our role. As of December 2018, Harmonization of Genetic Testing for Dogs database currently holds basic information for 59 genetic test providers across 17 countries, with information on quality measures and accreditation for 26 active and participating test providers - including non-profits, academic institutions, and for-profits. Our searchable genetic phenes database currently holds information on 300+ phenes across all breeds/types, and provides a plethora of information on each phene: links to OMIA, gene + mutations, a simple and advanced disease description, inheritance details, links to original publications, patents/licenses, comments from the original researchers/experts on application, and breed specific information (such as research/validation) - where possible. Our projects moving forward in 2019 are to continue to engage with researchers, veterinary experts, and test providers, and also to focus on the development of an expert panel for reviewing genetic testing resources, as well as interactive educational tools for consumers. In addition, we are looking for collaboration to address some common problems across genetic testing, such as nomenclature of genetic tests - which has been a significant challenge in harmonizing across international researchers and test developers. We are pleased that we continue to have sponsorship and support from many of our key Leadership Sponsors to develop our work for 2019. We would welcome anyone with an interest in contributing to, or participating in, the HGTD project to contact us. We are particularly keen to engage with academic and research institutions providing testing, who are concerned about ensuring genetic testing is a beneficial and responsible resource. Key Partners and Leadership Sponsors Read more about IPFD Partners and Sponsors Other potential sponsors and collaborators are welcome to contact us to explore opportunities. Contact: IPFD CEO Brenda.Bonnett@ipfdogs.com or Project Director Aimee.Llewellyn-Zaidi@ipfdogs.com “Wisdom Health and the Wisdom Health logo are trademarks of Mars, Incorporated and its affiliates. Used with permission.” -
In September 2019 the Orthopedic Foundation for Animals (OFA) posted several videos on YouTube... below we highlight several. These presentations are substantive in their coverage of the topics with a focus on improving health and welfare of dogs. The audience for these presentations is veterinarians, although dog breeders and breed club health managers can certainly benefit from viewing/sharing this content as well. Veterinarians can help guide clients in terms of selection of a dog that will fit with their lifestyle and expectations. Providing advice and services along these lines really can make a difference in welfare for the lifetime of the dog and client satisfaction once the critical selection of breed/dog has been made. -
Here you will find links to information on elbow dysplasia and testing schemes, including from the International Elbow Working Group, The Orthopedic Foundation for Animals (OFA), the British Veterinary Association (BVA) and the Fédération Cynologique Internationale (FCI). -
IPFD Harmonization of Genetic Testing for Dogs: Press Release
Brenda Bonnett posted a article in IPFD News
NOTE: Since this press release, as of April 2018, Harmonization of Genetic Testing for Dogs is online. Please check it out! The International Partnership for Dogs (IPFD) announces the “Harmonization of Genetic Testing for Dogs” initiative: to support the appropriate selection and use of DNA testing in dog health and breeding decisions The ever-increasing emergence of new canine DNA tests and testing laboratories has made choosing quality DNA testing providers and the right DNA tests for health and breeding decisions increasingly challenging for many owners, breeders and veterinarians. Working with a wide-spectrum of stakeholders in dog health, the International Partnership for Dogs (IPFD) "Harmonization of Genetic Testing for Dogs" initiative will provide practical support to address these challenges. -
Version 1.0.0
5 downloads
THIS IS AN OPEN ACCESS ARTICLE - YOU MAY READ OR DOWNLOAD THE ARTICLE AS PDF FROM THE PUBLISHER'S WEBSITE. Article links: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0172918 http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0172918&type=printable (PDF) A. M. Oberbauer1*, G. G. Keller2, T. R. Famula1 1 Department of Animal Science, University of California, Davis, Davis, CA United States of America, 2 Orthopedic Foundation for Animals, Columbia, MO United States of America "The objectives of the present study were to characterize the influence of non-compulsory selection on phenotypic radiographic assessment of hip and elbow conformation over time. Dog breeds that were most highly participatory in a voluntary United States radiographic screening process for hips and elbows were evaluated for improvement, whether maternal or paternal selection was more responsible for any observed progress, whether some breeds prove more amenable to selection than others, and whether selection against one orthopedic disorder yielded concomitant improvement in the other." Abstract "Canine hip dysplasia (CHD) and elbow dysplasia (ED) impact the health and welfare of all dogs. The first formally organized assessment scheme to improve canine health centered on reducing the prevalence of these orthopedic disorders. Phenotypic screening of jointconformation remains the currently available strategy for breeders to make selection decisions. The present study evaluated the efficacy of employing phenotypic selection on breed improvement of hips and elbows using the Orthopedic Foundation for Animals complete database spanning the 1970±2015 time period. Sixty breeds having more than 1000 unique hip evaluations and 500 elbow evaluations (1,056,852 and 275,129 hip and elbow records, respectively) were interrogated to derive phenotypic improvement, sex and age at time of assessment effects, correlation between the two joints, heritability estimates, estimated breeding values (EBV), and effectiveness of maternal/paternal selection. The data demonstrated that there has been overall improvement in hip and elbow conformation with a reduction in EBV for disease liability, although the breeds differed in the magnitude of the response to selection. Heritabilities also differed substantially across the breeds as did the correlation of the joints; in the absence of a universal association of these differences with breed size, popularity, or participation in screening, it appears that the breeds themselves vary in genetic control. There was subtle, though again breed specific, impact of sex and older ages on CHD and ED. There was greater paternal impact on a reduction of CHD. In the absence of direct genetic tests for either of these two diseases, phenotypic selection has proven to be effective. Furthermore, the data underscore thatselection schemes must be breed specific and that it is likely the genetic profiles will be unique across the breeds for these two conditions. Despite the advances achieved with phenotypic selection, incorporation of EBVs into selection schemes should accelerate advances in hip and elbow improvement." From the Discussion... "The data presented here confirms that employing phenotypic health information and selecting sires and dams from pedigrees free from dysplasia does reduce the condition. Acceptance of using health information in breeding decisions is growing. A 2004 study of Dutch Boxer breeders [75] indicated that 32% of the breeders utilized genetic information, expressed as an odds ratio of particular sire-dam combinations producing deleterious health traits, in their mate selections. A recent report assessing selection practices among Australian dog breeders indicated that the ªgenetics and healthº attribute of potential dams was one of the top four decision components [76]; despite this weighting in dam selection some breeders failed to practice health screening, including for CHD. As selection tools for health characteristics improve, using those will demonstrably improve the health of dogs." -
Many thanks to the AKC-CHF and our other sponsors for supporting the collaborative Harmonization of Genetic Testing initiative!!! See the Dog News Annual Issue for the complete article.
